Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
about
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repairAn epigenetic mechanism for capecitabine resistance in mesotheliomaLung cancer. 9: Molecular biology of lung cancer: clinical implications.Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcriptionCurrent limitations and future opportunities for epigenetic therapies.Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)DNA methylation analysis: a powerful new tool for lung cancer diagnosis.Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Pharmacogenetic candidate genes for melanoma.DNA methyltransferase inhibition may limit cancer cell growth by disrupting ribosome biogenesisDistinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesisModulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylationRegulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta.A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia.Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation.Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma5-azacytidine affects TET2 and histone transcription and reshapes morphology of human skin fibroblasts.Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB.Advances in preclinical small molecules for the treatment of NSCLC.High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.The pituitary tumour epigenome: aberrations and prospects for targeted therapy.DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells.Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage.Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116.
P2860
Q33331870-EBE927DC-7183-46F0-819D-45F86169C7B9Q33337445-5AB10CE6-7420-4778-AB0B-32CFC18B490AQ33344484-05ACA4CE-3F0B-4397-9A58-65CEAD5008A1Q33390536-3B186935-6ECF-4449-85DC-5A697D29BE7DQ33665187-C71A36DF-739D-4D55-832F-781F39570320Q33701400-81C126C1-0060-4A4D-85CA-87F92D7E4E43Q33813008-E0B0D946-2492-474E-AF53-6402975014F6Q33972805-F542EE8A-7461-44D1-A26A-16D870E8A6FCQ34042749-C14DC152-423D-43F4-83A8-3F7CCCF5A592Q34195077-C656BB1B-FAFB-4764-9C22-E1B647C77154Q34334443-F06D0546-2FBF-40DD-A7CA-25034540E633Q34396332-D4C9AEDF-CDEC-4F3A-ADD1-1E797B6903EFQ34510205-FA86AE3C-31B6-44C3-AFDC-E5035B8CC8C0Q34770585-F06D059B-8C96-4CD0-A3D1-145EFD846A5CQ35019557-BC90F091-A94A-4A21-B284-7EAF480FDEEFQ35136616-89FD1750-5200-4D2E-8EE0-B8ACC27FDC0EQ35574952-729268C9-23B9-4734-AA04-E5B90E1BAAF7Q35754814-4185B119-A453-43AF-A55B-70A607D7328DQ35919451-56EE1B2D-4E35-447E-AA29-4B6D09BD58ACQ36039537-2BC2CB19-12FF-43D2-831C-CCCF4D955E03Q36082658-4D69ABB6-825F-40EC-8F77-ECF5D1383DCDQ36140125-C4C6CC35-0473-4733-867F-39A217B96F45Q36395421-4E9D9564-BB95-4766-82ED-139A37FF6A5BQ36642513-D321D5ED-E1C0-47BF-A035-C67F47444EF4Q36710904-FE52F383-D02D-4D7E-9148-5D7CEE3CCF53Q37101927-C1F77728-B4BC-4D0A-875C-82BA4DFCFEF3Q37113556-69280AA5-AA27-47A0-98DA-328FCFF6D4A2Q37411965-7BC8F50B-6F04-46EC-98A7-4D5AD89C06E6Q37457679-22C07222-531F-446A-8CED-2870BD232D38Q37489942-6CCEEDF3-3FA0-4402-B5DD-78FF815AE798Q37655865-BA0440D3-D43E-46B6-96F5-B8A5ACA08120Q37706926-5C0C6972-7DA5-475E-B21E-E2C50A6F1826Q38004744-ADD3A7D4-FB92-43A3-A48C-725DCD995036Q39043256-05B0C151-A597-46B4-9269-A72C4D8983E2Q39722426-1651B467-E70E-406A-B2B8-3DC1F928E9ECQ39742078-3D9FC496-AAF2-4D9C-9524-465D2A52E950Q39992913-C8592AC6-2D90-4815-925A-1CEFCD60C5D1Q40020060-2E7ED628-83BA-479A-9CDE-0D69078B1E57Q40498918-4649C0DF-CDBE-437F-BFDF-0F47D50996E4Q40540679-33FC4E17-0A36-48ED-9CDE-13404D262EF8
P2860
Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Increased expression of unmeth ...... ne in human lung cancer cells.
@en
Increased expression of unmeth ...... ne in human lung cancer cells.
@nl
type
label
Increased expression of unmeth ...... ne in human lung cancer cells.
@en
Increased expression of unmeth ...... ne in human lung cancer cells.
@nl
prefLabel
Increased expression of unmeth ...... ne in human lung cancer cells.
@en
Increased expression of unmeth ...... ne in human lung cancer cells.
@nl
P2093
P356
P1433
P1476
Increased expression of unmeth ...... ne in human lung cancer cells.
@en
P2093
G A Otterson
K Srinivasan
M A Villalona-Calero
P2888
P304
P356
10.1038/SJ.ONC.1204970
P407
P50
P577
2001-11-01T00:00:00Z
P5875
P6179
1027237957